¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase variation"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bacterial variation
    ¼¼±Õ º¯ÀÌ
    ¼¼±ÕÀÌ µ¿Á¤°ú ºÐÈ­¸¦ ÇÏ´Â µ¥ ¾²À̴ Ư¡ÀÇ ¹üÀ§.
  • caliber variation
    ±¸°æ º¯·®
  • carcadian variation
    ?
  • diurnal variation
    ÁÖ°£ º¯µ¿, ÀÏÁÖ º¯È­
  • dose rate variation
    ¼±·®·ü º¯È­
  • interobserver variation
    °üÂûÀÚ°£ º¯ÀÌ
  • magnetic susceptibility variation
    ÀÚ±âÈ­À² º¯ÀÌ
  • monophasic variation
    ´Ü»ó¼º º¯È­
  • severe variation
    ½ÉÇÑ º¯Çü
  • variation
    º¯ÀÌ, º¯µ¿, º¯Çü
    À¯ÀüÇÐÀûÀ¸·Î °³Ã¼¿¡ ¼ÓÇÏ´Â ±ºÀÇ Æ¯À¯ÇÑ Æ¯¼ºÀ¸·ÎºÎÅÍÀÇ ÆíÂ÷. ÀÚ¼ÕÀÇ Æ¯¼ºÀÌ ¾î¹öÀÌÀÇ Æ¯¼ºÀ¸·ÎºÎÅÍ º¯À§µÇ´Â °Í.
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
    ¹Ì»ý¹° ¹è¾ç ½Ã °©Àڱ⠼ºÀåÀÌ Áõ°¡ÇÏ´Â ½Ã±â.
  • acute phase protein
    ±Þ¼º±â ´Ü¹éÁú
    °¨¿°À̳ª Á¶Á÷ ¼Õ»óÀÌ ÀÖÀ» ¶§ Á¤»óº¸´Ù 2-100¹è Á¤µµ Áõ°¡ÇÏ´Â Ç÷Àå ´Ü¹éÁúÀ» ÃÑĪÇÏ¿© APP¶ó°í ÇÏ¸ç ¼±Ãµ¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
  • acute phase reaction
    ±Þ¼º±â ¹ÝÀÀ
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
ÅëÇÕ°Ë»ö ¿Ï·á